External factors: | Erlotinib |
Aging type: | Accelerate |
Aging characteristic: |
Category: | Chemical compounds |
Phenotype: | Cervical cancer |
Experiment: | SA-β-gal activity assay |
Description: | The ability to form colonies decreased strongly after cells were treated with erlotinib for 6 8 days. During this time, a large percentage of surviving cells became positive for β-galactosidase , a marker for cell senescence. |
Regulatory pathway: | -- |
R-EF-Pathway: | -- |
Pathway experiment: | -- |
Pathway description: | -- |
Annotation: